alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
FORM 10-Q

Securities and Exchange Commission

Washington, D.C.  20549

(Mark One)

[X]	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE

SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended:  **March 31, 2001**
[   ]	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE 

SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______________ to _______________.

Commission File No. 0-22372.

GRAND TOYS INTERNATIONAL, INC.

(Exact name of Issuer as specified in its charter)	

		

	  Nevada	      					98-0163743 	 (State or other jurisdiction of					(I.R.S. Employer

incorporation or organization					Identification No.)

1710 Route Transcanadienne, Dorval, Quebec, Canada H9P 1H7

(Address of principal executive offices)

(514) 685-2180

(Registrant's telephone number)

 

(Former name, former address and former fiscal year, 

if changed since last report)

Indicate by check mark whether the Issuer (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act during the preceding 12 months (or for such shorter period that the registrant was requiredto file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes	    X   		No    _____

Indicate the number of shares outstanding of each of the Issuer's classes of common equity, as of May 11, 2001: 4,713,477.

 

 

 

 

 
**GRAND TOYS INTERNATIONAL, INC.

 

Index to Quarterly Report on Form 10 - Q

Filed with the Securities and Exchange Commission

Period ended March 31, 2001**ITEMS IN FORM 10 - Q **Page**Part I - Financial Information   
Item 1.  Consolidated Financial Statements:   
Consolidated Balance Sheets 

      at March 31, 2001 and December 31, 2000
3-4
Consolidated Statements of Operations

      For The Three Month Period

      Ended March 31, 2001 and 2000
5
Consolidated Statements of Stockholders' Equity and Comprehensive                                                             

      Income 
6
Consolidated Statements of Cash Flows

      For The Three Month Period

      Ended March 31, 2001 and 2000
7
Notes to Consolidated Financial Statements
8-17  
Item 2.  Management's Discussion and Analysis of Financial Condition

             and Results of Operations
18-22
Item 3. Quantitative and Qualitative Disclosures About Market Risks
23  **Part II - Other Information   
Item 1.  Legal proceedings
23
Item 2.  Changes in Securities and Use of Proceeds
23
Item 3.  Defaults Upon Senior Securities
23
Item 4.  Submission of Matters to a Vote of Security Holders
23
Item 5.  Other Information
23
Item 6.  Exhibits and Reports on Form 8-K
23  
Signatures
24-25** 

 

Part I. - Financial Information
***Item 1.  Financial Statements*
Consolidated Balance Sheets
 
March 31, 2001
December 31, 2000 
(Unaudited) **Assets     
Current assets:
Cash
$169,693
$211,515
Accounts receivable (net of allowance for doubtful	****************
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Nursing Research, Special Emphasis Panel, NINR Loan Repayment Program Review (L30/L40).                    

*Date:*                         March 29, 2010.                    

*Time:*                         9 a.m. to 12 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Ste. 710, Bethesda, MD 20892. (Telephone Conference Call)                    

*Contact Person:*                         Mario Rinaudo, MD, Scientific Review Administrator, Office of Review, National Institute of Nursing Research, National Institutes of Health, 6701 Democracy Blvd (DEM 1), Suite 710, Bethesda, MD 20892, 301-594-5973,                         *mrinaudo@mail.nih.gov.*

Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.

(Catalogue of Federal Domestic Assistance Program Nos. 93.361, Nursing Research, National Institutes of Health, HHS)

Dated: March 1, 2010.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 2010-4753 Filed 3-8-10; 8:45 am]

BILLING CODE 4140-01-M
Editorial Note on Part 880
Editorial Note: Nomenclature changes to part 880 appear at 73 FR 35341, June 23, 2008.

§ 880.5580 Acupuncture needle. ( a ) *Identification.* An acupuncture needle is a device intended to pierce the skin in the practice of acupuncture. The device consists of a solid, stainless steel needle. The device may have a handle attached to the needle to facilitate the delivery of acupuncture treatment.
( b ) *Classification.* Class II (special controls). The device, when it is an acupuncture point locator or a single use acupuncture needle, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 880.9. Acupuncture needles must comply with the following special controls: ( 1 ) Labeling for single use only and conformance to the requirements for prescription devices set out in 21 CFR 801.109,
( 2 ) Device material biocompatibility, and
( 3 ) Device sterility.
[61 FR 64617, Dec. 6, 1996, as amended at 84 FR 71815, Dec. 30, 2019]
Editorial Note on Part 874
Editorial Note: Nomenclature changes to part 874 appear at 73 FR 35341, June 23, 2008.

§ 874.1100 Earphone cushion for audiometric testing. ( a ) *Identification.* An earphone cushion for audiometric testing is a device that is used to cover an audiometer earphone during audiometric testing to provide an acoustic coupling (sound connection path) between the audiometer earphone and the patient's ear.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 874.9.
[51 FR 40389, Nov. 9, 1986; 52 FR 18495, May 15, 1987, as amended at 52 FR 32111, Aug. 25, 1987; 65 FR 2315, Jan. 14, 2000]
§ 80.34 Authority to refuse certification service. ( a ) When it appears to the Commissioner that a person has: ( 1 ) Obtained, or attempted to obtain, a certificate through fraud or misrepresentation of a material fact.
( 2 ) Falsified the records required to be kept by § 80.39; or
( 3 ) Failed to keep such records, or to make them available, or to accord full opportunity to make inventory of stocks on hand or otherwise to check the correctness of such records, as required by § 80.39; or
( 4 ) Refused to permit duly authorized employees of the Food and Drug Administration free access to all manufacturing facilities, processes, and formulae involved in the manufacture of color additives and intermediates from which such color additives are derived; he may immediately suspend certification service to such person and may continue such suspension until adequate corrective action has been taken.
( b ) Any person who contests suspension of service shall have an opportunity for a regulatory hearing before the Food and Drug Administration pursuant to part 16 of this chapter.
#### People of the State of Illinois, Plaintiff-Appellant, v. Frank Lio, Defendant-Appellee.

Gen. No. 68-178. (Abstract of Decision.)

Second District.

May 20, 1969.

William V. Hopf, State’s Attorney of Du Page County, of Wheaton, and Helen C. Kinney, Assistant State’s Attorney, for appellant; Desort and Krantz, of Chicago, for appellee.

Opinion by

JUSTICE ABRAHAMSON.

Not to be published in full.
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
       
<S>                                        <C>
<PERIOD-TYPE>                                    6-MOS
<FISCAL-YEAR-END>                          APR-30-1998
<PERIOD-END>                               OCT-31-1998
<CASH>                                         300,782
<SECURITIES>                                         0
<RECEIVABLES>                                  606,739
<ALLOWANCES>                                         0
<INVENTORY>                                     37,576
<CURRENT-ASSETS>                               945,097
<PP&E>                                       6,886,744
<DEPRECIATION>                             (1,264,806)
<TOTAL-ASSETS>                               6,898,077
<CURRENT-LIABILITIES>                        1,599,959
<BONDS>                                      3,538,309
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                    23,272,247
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                 6,898,077
<SALES>                                              0
<TOTAL-REVENUES>                             1,140,028
<CGS>                                                0
<TOTAL-COSTS>                                  627,921
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             193,304
<INCOME-PRETAX>                            (1,358,884)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                 89,343
<CHANGES>                                            0
<NET-INCOME>                               (1,269,541)
<EPS-PRIMARY>                                    (.27)
<EPS-DILUTED>                                    (.27)
        

</TABLE>
## SUPREME COURT OF THE STATE OF NEW YORK 

## Appellate Division, Fourth Judicial Department

**417 CA 13-01154**  PRESENT: SMITH, J.P., FAHEY, PERADOTTO, SCONIERS, AND VALENTINO, JJ.

PATRICIA KARAM, AS ADMINISTRATRIX OF THE ESTATE OF TONY KARAM, DECEASED, AND PATRICIA KARAM, INDIVIDUALLY, PLAINTIFF-APPELLANT-RESPONDENT,

V ORDER

ADIRONDACK NEUROSURGICAL SPECIALISTS, P.C., ET AL., DEFENDANTS, ST. ELIZABETH MEDICAL CENTER AND TIMOTHY EDWARD PAGE, DEFENDANTS-RESPONDENTS-APPELLANTS. (APPEAL NO. 2.)

JOEL M. KOTICK, NEW YORK CITY, POWERS & SANTOLA, LLP, ALBANY (MICHAEL J. HUTTER OF COUNSEL), FOR PLAINTIFF-APPELLANT-RESPONDENT.

SMITH, SOVIK, KENDRICK & SUGNET, P.C., SYRACUSE (LAURENCE F. SOVIK OF COUNSEL), FOR DEFENDANTS-RESPONDENTS-APPELLANTS.

Appeal and cross appeal from an order of the Supreme Court, Oneida County (Bernadette T. Clark, J.), entered May 21, 2013 in a medical malpractice and wrongful death action. The order, among other things, denied plaintiff’s motion to renew.

It is hereby ORDERED that the order so appealed from is unanimously affirmed without costs.

Entered: May 2, 2014 Frances E. Cafarell Clerk of the Court
**Exhibit 32.1**

 

**CERTIFICATION PURSUANT TO**

**SECTION 1350, CHAPTER 63 OF TITLE 18,UNITED STATES CODE,**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF2002**

 

Pursuant to Section 1350,Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906of the Sarbanes-Oxley Act of 2002, the undersigned, as Chief Executive Officerof The Timberland Company (the “Company”), does hereby certify that to theundersigned’s knowledge:

 

1.             The Company’sQuarterly Report on Form 10-Q for the period ending April 1, 2005fully complies with the requirements of Section 13(a) or 15(d) ofthe Securities Exchange Act of 1934; and

 

2.             The informationcontained in the Company’s Quarterly Report on Form 10-Q for the periodending April 1, 2005 fairly presents, in all material respects, thefinancial condition and results of operations of the Company.

 

 
|   /S/ JEFFREY B. SWARTZ |   |
|-----------------------------------|--------|
| Jeffrey B. Swartz                 |
| Chief Executive Officer           |
|                              |
| Date: May 10, 2005           |

 

The foregoing certification is being furnished solely pursuant to Section 906of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350,Chapter 63 of Title 18, United States Code) and is not being filed as part ofthe Form 10-Q or as a separate disclosure document.

 

A signed original of this written statement, required by Section 906,has been provided to The Timberland Company and will be retained by TheTimberland Company and furnished to the Securities and Exchange Commission orits staff upon request.

 

1

----
# C_2014431EN.01002502.xml

| 1.12.2014 | EN | Official Journal of the European Union | C 431/25 |
| --- | --- | --- | --- |

1.12.2014

EN

Official Journal of the European Union

C 431/25

---

Order of the President of the General Court of 4 September 2014 — Autoneum Germany v Commission

(Case T-295/14 R)

((Application for interim measures - State aid - National support for the generation of renewable electricity - Commission decision to open the State aid formal investigation procedure - Application for suspension of operation of a measure - Prima facie case))

(2014/C 431/44)

Language of the case: German

Parties

Parties

Applicant: Autoneum Germany GmbH (Roßdorf, Germany) (represented by: T. Volz and B. Wißmann, lawyers)

Applicant:

Defendant: European Commission (represented by: T. Maxian Rusche and R. Sauer, Agents)

Defendant:

Re:

Re:

Application to suspend the legal effects of the decision by which the Commission opened the State aid formal investigation procedure concerning the German law on renewable energy.

Operative part of the order

Operative part of the order

| 1. | The application for interim measures is dismissed. |
| --- | --- |

1.

The application for interim measures is dismissed.

| 2. | The costs are reserved. |
| --- | --- |

2.

The costs are reserved.

---
**EXHIBIT
      32.1**


SECTION
      1350 CERTIFICATION





I,
      Julie Smolyansky, certify, pursuant to 18 U.S.C. Section 1350, as adopted
      pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the
      Quarterly Report of Lifeway Foods, Inc. (the “Company”) on Form 10-QSB for nine
      month period ended September 30, 2007:




(1)
      Fully complies with the requirements of section 13(a) or 15(d) of the Securities
      Exchange Act of 1934; and




(2)
      That the information contained in the report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.




This
      written statement is being furnished to the Securities and Exchange Commission
      as an exhibit to such Form 10-QSB. A signed original of this written statement
      required by Section 906 has been provided to the Company and will be
      retained by the Company and furnished to the Securities and Exchange Commission
      or its staff upon request.




Date:
                November 14, 2007
            /s/
                Julie SmolyanskyJulie
                Smolyansky, Chief Executive Officer,President,
                and Director
EXHIBIT 11 - CALCULATION OF NET INCOME (LOSS) PER COMMON SHARE


                                 MICROAGE, INC.
                 NET INCOME (LOSS) PER COMMON SHARE CALCULATION
                                 (in thousands)
<TABLE>
<CAPTION>
                                               Quarter ended         39 weeks ended
                                           ---------------------  --------------------
                                           August 2,  August 3,   August 2,  August 3,
                                             1998       1997        1998       1997
                                            -------   -------     --------    -------
<S>                                          <C>       <C>          <C>        <C>
BASIC
 Weighted average common shares              19,859    16,489       19,633     16,378
                                            -------   -------     --------    -------
DILUTED
 Weighted average shares from
  basic calculation                          19,859    16,489       19,633     16,378

 Dilutive effect of stock options
  and warrants                                  446       777           --        783
                                            -------   -------     --------    -------
   Weighted average common and common
   equivalent shares outstanding - diluted   20,305    17,266       19,633     17,161
                                            -------   -------     --------    -------

NET INCOME  (LOSS)                          $    26   $ 6,353     $(12,047)   $17,799

Net income (loss) per common and
 common equivalent share:
   Basic                                    $  0.00   $  0.39     $  (0.61)   $  1.09
                                            =======   =======     ========    =======
   Diluted                                  $  0.00   $  0.37     $  (0.61)   $  1.04
                                            =======   =======     ========    =======
</TABLE>
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT
No. 95-7382
ROOSEVELT ISAAC, Plaintiff - Appellant, versus P. DOUGLAS TAYLOR; NATHANIEL WATSON; JOE BLACK, Defendants - Appellees.
Appeal from the United States District Court for the District of South Carolina, at Columbia. Dennis W. Shedd, District Judge. (CA-94-2O03-3-19-BC) Submitted: January 11, 1996 Decided: January 24, 1996 Before RUSSELL, HALL, and WILKINSON, Circuit Judges. Affirmed by unpublished per curiam opinion. Robert Isaac, Appellant Pro Se. Joseph Crouch Coleman, Columbia, South Carolina, for Appellees. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).2 PER CURIAM:Appellant appeals from the district court's order denying relief on his 42 U.S.C. § 1983 (1988) complaint. We have reviewed the record and the district court's opinion accepting the magistrate judge's recommendation and find no reversible error. Accordingly, we affirm on the reasoning of the district court. Isaac v. Taylor , No. CA-94-2003-3-19-BC (D.S.C. Aug. 15, 1995). We dispense withoral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

AFFIRMED
#### Thomas Misuraca *v.*Peter Oleski

*James D. Mirabile,*in support of the petition.

*JoTm F. Murphy, Jr.,*in opposition.

Submitted August 30

decided September 18, 1968

The petition by the plaintiff for certification for appeal from the Appellate Division of the Circuit Court is denied.
Court of Appeals of the State of Georgia

Clerk's Office, Atlanta, July 31, 2018.

I certify that the above is a true extract from the minutes 

of the Court of Appeals of Georgia.

Witness my signature and the seal of said court hereto 

affixed the day and year last above written.

, Clerk.

Court of Appeals 

of the State of Georgia

ATLANTA, July 31, 2018

The Court of Appeals hereby passes the following order

A18D0540. EXECUTIVE LIMOUSINE TRANSPORTATION, INC. v. GEORGIA 

COMMISSIONER OF LABOR et al. .

Upon consideration of the Application for Discretionary Appeal, it is ordered that it be 

hereby DENIED.

LC NUMBERS:

2017CV288647
§ 71.37 Exemption of color additives for investigational use. ( a ) A shipment or other delivery of a color additive or of a food, drug, or cosmetic containing such a color additive for investigational use by experts qualified to determine safety shall be exempt from the requirements of section 402(c), 501(a), or 601(e) of the act, provided that the color additive or the food, drug, or cosmetic containing the color additive bears a label which states prominently, “Caution—Contains new color additive—For investigational use only.” No animals used in such investigations, or their products, such as milk or eggs, shall be used for food purposes, unless the sponsor or the investigator has submitted to the Commissioner data demonstrating that such use will be consistent with the public health, and the Commissioner, proceeding as he would in a matter involving section 409(i) of the act, has notified the sponsor or investigator that the proposed disposition for food is authorized. Any person who contests a refusal to grant such authorization shall have an opportunity for a regulatory hearing before the Food and Drug Administration pursuant to part 16 of this chapter.
( b ) The person who introduced such shipment or who delivers the color additive or a food, drug, or cosmetic containing such an additive into interstate commerce shall maintain adequate records showing the name and post-office address of the expert to whom the color additive is shipped, date, quantity, and batch or code mark of each shipment and delivery for a period of 2 years after such shipment and delivery. Upon the request of a properly authorized employee of the Department, at reasonable times, he shall make such records available for inspection and copying.
1 The Honorable William R. Wilson, United St ates District Judge for the Eastern District of Arkansas. 

## United States Court of Appeals FOR THE EIGHTH CIRCUIT

___________ No. 08-2130

___________ Carolyn Miles, * * Appellant, * * Appeal from the United States v. * District Court for the * Eastern District of Arkansas. University of Arkansas System, * * [UNPUBLISHED] Appellee. *

___________ Submitted: October 6, 2009 Filed: October 8, 2009

___________ Before BYE, BOWMAN, and BENTON, Circuit Judges.

___________ PER CURIAM. Carolyn Miles appeals the District Court’s 1 adverse grant of summary judgment in her employment-discrimination suit. After de novo review, see Johnson v. Blaukat , 453 F.3d 1108, 1112 (8th Cir. 2006) , we conclude that summary judgment was proper for the reasons stated by the District C ourt. Accordingly, we affirm. See8th Cir. R. 47B.